You are here

Article Text

Article menu
Download PDFPDF
Miscellaneous
Letter
Risk perception in MSM taking prep: a survey
  1. G Whitlock,
  2. S Boccino,
  3. U Kanagalinghan,
  4. N Nwokolo
  1. Chelsea & Westminster Hospital NHS Foundation Trust, London, UK
  1. Correspondence to Dr Gary Whitlock, 56 Dean Street, Chelsea & Westminster Hospital NHS Foundation Trust, London W1D 6AQ, UK; gary.whitlock{at}chelwest.nhs.uk

https://doi.org/10.1136/sextrans-2016-053050

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    There are concerns that those taking HIV pre-exposure prophylaxis (PrEP) may increase their frequency of condomless sexual intercourse and, hence, their risk of acquiring STIs other than HIV. To date, PrEP is not available in England on the National Health Service (NHS). In September 2015, at 56 Dean Street, we opened a weekly PrEP clinic which offers single tablet Truvada (tenofovir/emtricitabine) at cost price, and in February 2016, we initiated PrEP monitoring in the general sexual …

    View Full Text

    Footnotes

    • Contributors GW and NN came up with the idea and analysed the data. SB and UK collected and input data.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.